Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1309297
                    [Title] => Gamot sa breast cancer ni-recall
                    [Summary] => 
Nagbabala ang Food and Drug Administration (FDA) sa publiko laban sa isang batch ng gamot para sa breast cancer na sinasabing boluntaryo namang ini-recall ng manufacturer.

                    [DatePublished] => 2014-04-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1478575
                    [AuthorName] => Ludy Bermudo
                    [SectionName] => Bansa
                    [SectionUrl] => bansa
                    [URL] => http://media.philstar.com/images/pilipino-star-ngayon/bansa/20140406/gamot-sa-cancer.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1309353
                    [Title] => Drugs for heart ailments, breast cancer recalled from market
                    [Summary] => 
The Food and Drug Administration (FDA) yesterday cautioned the public against certain batches of medicine for heart ailments and for breast cancer, which were recalled from the Philippine market following complaints.

                    [DatePublished] => 2014-04-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 703067
                    [Title] => Roche's drug receives broader EU label  for women with metastatic breast cancer
                    [Summary] => 
BASEL, Switzerland — Roche announced this week that the European Commission (EC) has extended the existing bevacizumab metastatic breast cancer label to include combination with capecitabine.
                    [DatePublished] => 2011-07-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

PACLITAXEL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1309297
                    [Title] => Gamot sa breast cancer ni-recall
                    [Summary] => 
Nagbabala ang Food and Drug Administration (FDA) sa publiko laban sa isang batch ng gamot para sa breast cancer na sinasabing boluntaryo namang ini-recall ng manufacturer.

                    [DatePublished] => 2014-04-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1478575
                    [AuthorName] => Ludy Bermudo
                    [SectionName] => Bansa
                    [SectionUrl] => bansa
                    [URL] => http://media.philstar.com/images/pilipino-star-ngayon/bansa/20140406/gamot-sa-cancer.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1309353
                    [Title] => Drugs for heart ailments, breast cancer recalled from market
                    [Summary] => 
The Food and Drug Administration (FDA) yesterday cautioned the public against certain batches of medicine for heart ailments and for breast cancer, which were recalled from the Philippine market following complaints.

                    [DatePublished] => 2014-04-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 703067
                    [Title] => Roche's drug receives broader EU label  for women with metastatic breast cancer
                    [Summary] => 
BASEL, Switzerland — Roche announced this week that the European Commission (EC) has extended the existing bevacizumab metastatic breast cancer label to include combination with capecitabine.
                    [DatePublished] => 2011-07-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Gamot sa breast cancer ni-recall

By Ludy Bermudo | April 6, 2014 - 12:00am

Nagbabala ang Food and Drug Administration (FDA) sa publiko laban sa isang batch ng gamot para sa breast cancer na sinasabing...

Bansa

Drugs for heart ailments, breast cancer recalled from market

By Sheila Crisostomo | April 6, 2014 - 12:00am

The Food and Drug Administration (FDA) yesterday cautioned the public against certain batches of medicine for heart ailments and for breast cancer, which were recalled from the Philippine market following compl...

Headlines

Roche's drug receives broader EU label for women with metastatic breast cancer

July 7, 2011 - 12:00am

BASEL, Switzerland — Roche announced this week that the European Commission (EC) has extended the existing bevacizumab metastatic breast cancer label to include combination with capecitabine.

Science and Environment